Physician profile
Sonia Koshy
NPI 1588185862
$3,275.99
in general payments reported to CMS, 2019-2025
20 companies · $1,797 in 2025
The $1,797 reported for 2025 was more than what 89% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.81 · 2022: $182 · 2023: $1,050 · 2024: $230 · 2025: $1,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,825 · Food and Beverage: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,825.00 |
| Food and Beverage | $1,252.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,586.08 | 2022-2025 | |
| Medical Device Business Services, INC. | $325.00 | 2023 | |
| Myriad Genetic Laboratories, INC. | $315.87 | 2023-2024 | Myrisk, Precisetumor |
| Sumitomo Pharma America, INC. | $198.23 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $126.40 | 2023-2025 | Veozah |
| Minerva Surgical, INC | $112.76 | 2023 | |
| Merck Sharp & Dohme LLC | $104.17 | 2024 | Keytruda, Lynparza |
| Medtronic, INC. | $77.07 | 2022 | |
| Glaxosmithkline, LLC. | $71.93 | 2023-2024 | Jemperli, Zejula |
| Seagen INC. | $63.46 | 2023 | Tivdak |
| Integra Lifesciences Corporation | $49.32 | 2025 | Integra, Surgimend, Omnigraft |
| Exeltis, USA INC. | $38.53 | 2025 | Slynd |
| Baxter Healthcare | $37.75 | 2025 | Tisseel |
| Ethicon US, LLC | $37.67 | 2023 | Stratafix |
| Clovis Oncology, INC. | $35.66 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $26.04 | 2025 | |
| Olympus America INC. | $23.60 | 2023 | Olympus |
| Organon LLC | $18.44 | 2025 | Nexplanon |
| Immunogen, INC. | $14.80 | 2023 | Elahere |
| Aspira Women'S Health INC | $13.21 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Koshy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.